United Kingdom

Synonyms: 
U.K.
UK
Wales
Britain
England
Tue
17
Sep

UK company set to be largest cannabis company on London stock market

A UK company is planning to list a £100m float on the stock market – poising it be the biggest cannabis company on the London Stock Exchange.

Cannaray, a British medical cannabis company, closed last Monday with a £7.8m (~€8.8m) Series A Funding round and hopes to raise more than £30m in the coming year in the hope of floating the £100m value.

Fri
06
Sep

10 historical figures who loved cannabis

You definitely learned a thing or two about these notable figures during your classroom studies, but we bet your teacher didn’t mention that they all smoked weed. We’re here to school you.

People love smoking weed. They always have, and they always will. So, it should come as no surprise that some of our favorite historical figures we learned about in school dabbled in the recreational (and medicinal!) cannabis scene.

Fri
06
Sep

UK advised to recruit former drug dealers if marijuana is legalised

Former drug dealers should be recruited and trained to produce safe, legal cannabis if the UK decides to legalise marijuana, the head of an American programme overseeing the sale of the narcotic has urged.

The Commissioner in charge of legal cannabis sales in Massachusetts has said Britain should follow her state’s example of recruiting ex-drug dealers and people from communities involved in what was once the underground market for marijuana.

Thu
05
Sep

African foothold for U.K. entrepreneurs in Tandem with Aphria

With the backing of a Canadian cannabis giant two British entrepreneurs have established a new CBD production plant in Africa’s most developed cannabis nation.

Lesotho has a history of illegal cannabis production stretching back centuries and became the first African country to approve medical pot cultivation in 2017. Shortly after legalization Ontario-based Aphria launched a joint venture with U.K. extraction company Verve Dynamics. This JV, known as Cann Invest Africa, aims to export Lesotho CBD to global markets. 

Wed
04
Sep

Golfers and rugby players show cannabis is going mainstream in sport

The first time I saw Charley Hoffman play, you would not have looked at him twice. That was at the Masters in 2015, where he stopped by the 1st tee box to beg autographs off Arnold Palmer and Jack Nicklaus. He was 38 already, a little tubby, a little schlubby, in a hat that looked two sizes too big and a pair of wraparound sunglasses so tight they gave him tan lines. Then he went and shot a 67. Well, like the old salts say at Augusta, the bars of Chicago are full of people who led majors after one round and Charley finished up tied ninth. But still, after 15 years playing pro golf, it was his first top-20 finish in a major.

Tue
03
Sep

The cannabis industry in the UK: Risky business?

Is the cannabis industry in the UK a risky business? John Binns, Partner at BCL Solicitors LLP finds out more

Few can have failed by now to spot that cannabis and cannabis derivatives, are increasingly big business, not only in countries like Canada, but also right here in the UK. But the question of how this brave new world fits with the UK’s institutional attitude towards cannabis is an important one and divides into domestic and international issues.

Mon
02
Sep

Boris Johnson appoints cannabis backers to his team

Hopes for a more liberal approach to cannabis regulations from the Boris Johnson Government have risen with the appointment of two cannabis supporters to his team.

Mon
02
Sep

Sundial to grow U.K. CBD after buying supermarket supplier

Following a C$250 million boost, Canadian firm Sundial Growers has splashed out one of the U.K’s largest horticultural operations to supply the booming European CBD market.

Thu
29
Aug

Second GW pharmaceutical setback exposes U.K. health system flaws

The U.K. medical body charged with determining which treatments can be accessed through the National Health Service (NHS) has dealt a second blow to GW Pharmaceuticals in a matter of days.

Last week, in its findings on the potential for U.K. medical cannabis, NICE  (The National Institute for Health and Care Excellence) ruled GW’s Multiple Sclerosis drug Sativex as not cost effective.

And it has now delivered the same verdict on its epilepsy drug Epidiolex – for the time being, at least.

Pages

Subscribe to RSS - United Kingdom